[go: up one dir, main page]

UA85707C2 - Бензоксазины для лечения заболеваний дыхательных путей - Google Patents

Бензоксазины для лечения заболеваний дыхательных путей

Info

Publication number
UA85707C2
UA85707C2 UAA200612036A UAA200612036A UA85707C2 UA 85707 C2 UA85707 C2 UA 85707C2 UA A200612036 A UAA200612036 A UA A200612036A UA A200612036 A UAA200612036 A UA A200612036A UA 85707 C2 UA85707 C2 UA 85707C2
Authority
UA
Ukraine
Prior art keywords
respiratory tract
benzoxazines
treating respiratory
tract diseases
relates
Prior art date
Application number
UAA200612036A
Other languages
English (en)
Ukrainian (uk)
Inventor
Т'єрі Буісу
Інго Конетцкі
Забіне Пестель
Андреас Шнапп
Крістоф Хьонке
Філіпп Лустенбергер
Клаус Рудольф
Курт Шромм
Франк Бюттнер
Клаудіа Хайне
Херманн Шолленбергер
Original Assignee
Бьорінгер Інгельхайм Інтернаціональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бьорінгер Інгельхайм Інтернаціональ Гмбх filed Critical Бьорінгер Інгельхайм Інтернаціональ Гмбх
Publication of UA85707C2 publication Critical patent/UA85707C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

В заявке описано применение соединений общей формулы 1 EMBED ISISServer , 1 в которой остатки R1, R2 и R3 могут иметь отмеченные в формуле изобретения и в описании значения, для получения лекарственного средства, предназначенного для лечения заболеваний дыхательных путей.
UAA200612036A 2004-04-22 2005-04-18 Бензоксазины для лечения заболеваний дыхательных путей UA85707C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen

Publications (1)

Publication Number Publication Date
UA85707C2 true UA85707C2 (ru) 2009-02-25

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200612036A UA85707C2 (ru) 2004-04-22 2005-04-18 Бензоксазины для лечения заболеваний дыхательных путей

Country Status (20)

Country Link
EP (1) EP1765355B1 (ru)
JP (1) JP2007533684A (ru)
KR (2) KR20130042662A (ru)
CN (1) CN1946406A (ru)
AU (1) AU2005235420C1 (ru)
BR (1) BRPI0510084A (ru)
CA (1) CA2559700C (ru)
DE (1) DE102004019539A1 (ru)
DK (1) DK1765355T3 (ru)
EA (1) EA012045B1 (ru)
EC (1) ECSP066948A (ru)
ES (1) ES2403184T3 (ru)
IL (1) IL177663A (ru)
NO (1) NO20065061L (ru)
NZ (1) NZ551272A (ru)
PL (1) PL1765355T3 (ru)
SG (1) SG152233A1 (ru)
UA (1) UA85707C2 (ru)
WO (1) WO2005102350A1 (ru)
ZA (1) ZA200606547B (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
EP1917253B1 (de) 2005-08-15 2015-01-07 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von betamimetika
AU2006311060A1 (en) * 2005-11-09 2007-05-18 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
JP5584138B2 (ja) 2008-01-11 2014-09-03 ノバルティス アーゲー キナーゼ阻害剤としてのピリミジン類
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
AU2012220572A1 (en) 2011-02-25 2013-08-29 Irm Llc Compounds and compositions as trk inhibitors
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
CN110062625A (zh) 2016-12-12 2019-07-26 勃林格殷格翰国际有限公司 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
CN120583945A (zh) 2023-01-20 2025-09-02 阿托基公司 用于治疗或预防肌肉消耗的β2-肾上腺素能受体激动剂
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
AU5629301A (en) * 2000-04-27 2001-11-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel, slow-acting betamimetics, a method for their production and their use as medicaments
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
AU2005235420C1 (en) 2011-02-24
KR101338947B1 (ko) 2013-12-10
CA2559700C (en) 2013-06-11
NZ551272A (en) 2010-10-29
EP1765355A1 (de) 2007-03-28
ZA200606547B (en) 2008-04-30
IL177663A0 (en) 2006-12-31
ES2403184T3 (es) 2013-05-16
IL177663A (en) 2014-04-30
AU2005235420B2 (en) 2010-10-28
DE102004019539A1 (de) 2005-11-10
DK1765355T3 (da) 2013-04-08
BRPI0510084A (pt) 2007-10-16
EA200601837A1 (ru) 2007-04-27
WO2005102350A1 (de) 2005-11-03
CA2559700A1 (en) 2005-11-03
NO20065061L (no) 2006-11-07
JP2007533684A (ja) 2007-11-22
ECSP066948A (es) 2006-12-20
CN1946406A (zh) 2007-04-11
EP1765355B1 (de) 2013-03-06
KR20070054599A (ko) 2007-05-29
EA012045B1 (ru) 2009-08-28
AU2005235420A1 (en) 2005-11-03
PL1765355T3 (pl) 2013-08-30
SG152233A1 (en) 2009-05-29
KR20130042662A (ko) 2013-04-26

Similar Documents

Publication Publication Date Title
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
TW200738242A (en) Dihydropteridinones in the treatment of respiratory diseases
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
TW200612910A (en) Medicaments comprising carbonyl compounds, and the use thereof
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
GEP20115357B (en) Amine derivatives
UA83233C2 (ru) Замещенный 2-аминотетралин для лечения депрессии
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
WO2005111002A3 (de) Substituierte cycloalkylderivate zur behandlung von atemswegerkrankungen
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
UA96304C2 (en) 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
TW200716547A (en) Piperidin-4-yl-amide derivatives
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.